Suheung Co., Ltd. (008490.KS)
KRW 12880.0
(-1.68%)
KRW 12880.0
(-1.68%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 74 Billion KRW | -57.2% |
| 2022 | 172.93 Billion KRW | 25.73% |
| 2021 | 137.54 Billion KRW | 17.45% |
| 2020 | 117.1 Billion KRW | -33.8% |
| 2019 | 176.9 Billion KRW | 49.19% |
| 2018 | 118.57 Billion KRW | 64.47% |
| 2017 | 72.09 Billion KRW | -39.79% |
| 2016 | 119.74 Billion KRW | -18.64% |
| 2015 | 147.18 Billion KRW | 31.72% |
| 2014 | 111.74 Billion KRW | -5.9% |
| 2013 | 118.75 Billion KRW | -33.05% |
| 2012 | 177.37 Billion KRW | 74.89% |
| 2011 | 101.41 Billion KRW | 141.39% |
| 2010 | 42.01 Billion KRW | 27.66% |
| 2009 | 32.91 Billion KRW | -38.46% |
| 2008 | 53.47 Billion KRW | 52.47% |
| 2007 | 35.07 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 71.96 Billion KRW | -2.75% |
| 2024 Q2 | 78.34 Billion KRW | 8.85% |
| 2023 FY | 74 Billion KRW | -57.2% |
| 2023 Q4 | 74 Billion KRW | -1.32% |
| 2023 Q1 | 177.15 Billion KRW | 2.44% |
| 2023 Q3 | 74.99 Billion KRW | -50.71% |
| 2023 Q2 | 152.14 Billion KRW | -14.12% |
| 2022 Q1 | 122.8 Billion KRW | -10.72% |
| 2022 FY | 172.93 Billion KRW | 25.73% |
| 2022 Q4 | 172.93 Billion KRW | 6.41% |
| 2022 Q3 | 162.51 Billion KRW | 15.31% |
| 2022 Q2 | 140.93 Billion KRW | 14.77% |
| 2021 FY | 137.54 Billion KRW | 17.45% |
| 2021 Q1 | 125.98 Billion KRW | 7.58% |
| 2021 Q3 | 142.83 Billion KRW | 90.52% |
| 2021 Q4 | 137.54 Billion KRW | -3.7% |
| 2021 Q2 | 74.96 Billion KRW | -40.49% |
| 2020 Q3 | 166.09 Billion KRW | -6.83% |
| 2020 Q2 | 178.26 Billion KRW | 1.48% |
| 2020 Q1 | 175.65 Billion KRW | -0.7% |
| 2020 FY | 117.1 Billion KRW | -33.8% |
| 2020 Q4 | 117.1 Billion KRW | -29.49% |
| 2019 Q4 | 176.9 Billion KRW | -2.74% |
| 2019 FY | 176.9 Billion KRW | 49.19% |
| 2019 Q3 | 181.87 Billion KRW | -0.99% |
| 2019 Q2 | 183.7 Billion KRW | 49.27% |
| 2019 Q1 | 123.07 Billion KRW | 3.79% |
| 2018 FY | 118.57 Billion KRW | 64.47% |
| 2018 Q1 | 74.31 Billion KRW | 3.08% |
| 2018 Q2 | 74.7 Billion KRW | 0.52% |
| 2018 Q3 | 133.76 Billion KRW | 79.07% |
| 2018 Q4 | 118.57 Billion KRW | -11.36% |
| 2017 Q1 | 120.61 Billion KRW | 0.72% |
| 2017 FY | 72.09 Billion KRW | -39.79% |
| 2017 Q4 | 72.09 Billion KRW | -14.16% |
| 2017 Q3 | 83.99 Billion KRW | -28.27% |
| 2017 Q2 | 117.09 Billion KRW | -2.91% |
| 2016 FY | 119.74 Billion KRW | -18.64% |
| 2016 Q4 | 119.74 Billion KRW | 0.04% |
| 2016 Q2 | 142.69 Billion KRW | -4.55% |
| 2016 Q3 | 119.69 Billion KRW | -16.12% |
| 2016 Q1 | 149.49 Billion KRW | 1.57% |
| 2015 Q3 | 153.53 Billion KRW | 67.53% |
| 2015 Q4 | 147.18 Billion KRW | -4.14% |
| 2015 FY | 147.18 Billion KRW | 31.72% |
| 2015 Q2 | 91.65 Billion KRW | 0.03% |
| 2015 Q1 | 91.62 Billion KRW | -18.01% |
| 2014 Q2 | 143.17 Billion KRW | 11.48% |
| 2014 Q1 | 128.43 Billion KRW | 8.15% |
| 2014 Q3 | 133.69 Billion KRW | -6.62% |
| 2014 FY | 111.74 Billion KRW | -5.9% |
| 2014 Q4 | 111.74 Billion KRW | -16.42% |
| 2013 FY | 118.75 Billion KRW | -33.05% |
| 2013 Q4 | 118.75 Billion KRW | -11.23% |
| 2013 Q3 | 133.77 Billion KRW | -21.31% |
| 2013 Q2 | 169.99 Billion KRW | -12.91% |
| 2013 Q1 | 195.19 Billion KRW | 10.05% |
| 2012 Q1 | 109.95 Billion KRW | 0.0% |
| 2012 Q4 | 177.37 Billion KRW | 0.0% |
| 2012 FY | 177.37 Billion KRW | 74.89% |
| 2011 FY | 101.41 Billion KRW | 141.39% |
| 2011 Q3 | 59.95 Billion KRW | 18.97% |
| 2011 Q2 | 50.39 Billion KRW | 100.43% |
| 2011 Q1 | 25.14 Billion KRW | 0.0% |
| 2010 Q1 | 588.94 Million KRW | 0.0% |
| 2010 Q3 | 9.89 Billion KRW | 45.9% |
| 2010 FY | 42.01 Billion KRW | 27.66% |
| 2010 Q2 | 6.78 Billion KRW | 1051.71% |
| 2009 FY | 32.91 Billion KRW | -38.46% |
| 2009 Q3 | 20.79 Billion KRW | -19.72% |
| 2009 Q2 | 25.9 Billion KRW | -6.42% |
| 2009 Q1 | 27.67 Billion KRW | 0.0% |
| 2008 Q1 | 28.97 Billion KRW | 0.0% |
| 2008 FY | 53.47 Billion KRW | 52.47% |
| 2008 Q2 | 29.03 Billion KRW | 0.21% |
| 2008 Q3 | 28.57 Billion KRW | -1.6% |
| 2007 Q3 | 16.71 Billion KRW | -0.69% |
| 2007 Q1 | 22.07 Billion KRW | 0.0% |
| 2007 FY | 35.07 Billion KRW | 0.0% |
| 2007 Q2 | 16.82 Billion KRW | -23.76% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -442.572% |
| Dong-A Socio Holdings Co., Ltd. | 202.06 Billion KRW | 63.374% |
| Ildong Holdings Co., Ltd. | 29.87 Billion KRW | -147.709% |
| HANDOK Inc. | 123.78 Billion KRW | 40.211% |
| Kukje Pharma Co., Ltd. | 475.74 Million KRW | -15456.105% |
| Yuhan Corporation | 60.23 Billion KRW | -22.866% |
| Dong-A ST Co., Ltd. | 161.99 Billion KRW | 54.314% |
| SAMSUNG PHARM. Co., LTD. | 101.81 Million KRW | -72585.775% |
| Hanmi Pharm. Co., Ltd. | 82.02 Billion KRW | 9.779% |
| Hanall Biopharma Co.,Ltd | 590.3 Million KRW | -12436.998% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -1123.257% |
| Dong Sung Bio Pharm.Co.,Ltd. | 18.52 Billion KRW | -299.554% |
| MYUNGMOON Pharm co.,Ltd | 12.58 Billion KRW | -488.095% |
| Hana Pharm Co., Ltd. | 1.59 Billion KRW | -4528.779% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -442.572% |
| Ilsung Pharmaceuticals Co., Ltd. | 119.67 Million KRW | -61738.268% |
| REYON Pharmaceutical Co., Ltd. | 121 Billion KRW | 38.837% |
| Aprogen pharmaceuticals,Inc. | 32 Billion KRW | -131.272% |
| JW Holdings Corporation | 20.65 Billion KRW | -258.26% |
| Ildong Pharmaceutical Co., Ltd. | 14.82 Billion KRW | -399.198% |
| Chong Kun Dang Pharmaceutical Corp. | 30 Billion KRW | -146.69% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -146.69% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -33699.193% |
| Hyundai Pharmaceutical Co., Ltd. | 580.64 Million KRW | -12645.638% |
| Samil Pharmaceutical Co.,Ltd | 49.56 Billion KRW | -49.303% |
| Jeil Pharmaceutical Co.,Ltd | 4.45 Billion KRW | -1562.331% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -442.572% |
| Kwang Dong Pharmaceutical Co., Ltd. | 19.02 Billion KRW | -288.945% |
| Daewoong pharmaceutical Co.,Ltd | 93.41 Billion KRW | 20.776% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -146.69% |
| Yuhan Corporation | 60.23 Billion KRW | -22.866% |
| Jeil Pharma Holdings Inc | 10.5 Billion KRW | -604.829% |
| Yungjin Pharm. Co., Ltd. | 40.37 Billion KRW | -83.286% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -146.69% |
| Samjin Pharmaceuticals Co., Ltd. | 4.16 Billion KRW | -1676.181% |
| Korea United Pharm Inc. | 10.96 Billion KRW | -575.093% |
| CKD Bio Corp. | 69.43 Billion KRW | -6.591% |
| Daewon Pharmaceutical Co., Ltd. | 34.57 Billion KRW | -114.049% |
| Dongwha Pharm.Co.,Ltd | 16.12 Billion KRW | -358.882% |
| Whan In Pharm Co.,Ltd. | 307.05 Million KRW | -24002.117% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -33699.193% |
| Chong Kun Dang Holdings Corp. | 72.11 Billion KRW | -2.627% |
| Boryung Corporation | 151.7 Billion KRW | 51.217% |
| Bukwang Pharmaceutical Co., Ltd. | 78.52 Billion KRW | 5.754% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -1123.257% |
| JW Lifescience Corporation | 168 Million KRW | -43951.816% |